Irodalom:
1. Abraham SC, Krasinskas AM, Correa AM, Hofstetter WL, Ajani JA, Swisher SG, Wu TT.: Duplication
of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging
of adenocarcinoma. Am J Surg Pathol 2007;31:1719-25.
2. Anagnostopoulos GK, Yao K, Kaye P, Hawkey CJ, Ragunath K.: Novel endoscopic observation in Barrett’s
oesophagus using high resolution magnification endoscopy and narrow band imaging. Aliment Pharmacol
Ther 2007;26:501-7.
3. Belhadj Amor M, Dakhlaoui J, Souissi H, Balma A, Labbène I, Ferjani M.: [Hyperbaric oxygen therapy as
an adjunctive treatment for acute mediastinitis due to oesophageal perforation: a case report]. Ann Fr
Anesth Reanim 2007;26:862-4.
4. Brook RA, Wahlqvist P, Kleinman N, Wallanders MA, Capbell SM, Smedding JM.: Cost of gastrooesophageal
reflux disease to the employer: a perspective from the United States. Aliment Pharmacol Ther
2007; 26:889-898.
5. Carmona-Sánchez R, Sánchez-Hermosillo E.: [Clinical images in gastroenterology. Eosinphilic esophagitis].
Rev Gastroenterol Mex 2007;72:154.
6. Carter RR, Coughenour JP, Van Way CW 3rd, Goldstrich J.: Acute esophageal necrosis with pneumomediastinum:
a case report. Mo Med 2007;104:276-8.
7. Cengia G, Missale G, Minelli L, Villanacci V, Rossi E, Cestari R.: Screening for and surveillance of
Barrett’s esophagus is clinically indicated. Dig Dis 2007;25:197-202.
8. Cohen MS, Kaufman AB, Palazzo JP, Nevin D, Dimarino AJ Jr, Cohen S.: An audit of endoscopic
complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2007;5:1149-53.
9. Dvorak K, Chavarria M, Payne CM, Ramsey L, Crowley-Weber C, Dvorakova B, Dvorak B, Bernstein
H, Holubec H, Sampliner RE, Bernstein C, Prasad A, Green SB, Garewal H.: Activation of the
interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance
to Barrett’s esophagus. Clin Cancer Res 2007;13:5305-13.
52 Gastro Update 2008
10. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL.: Central adiposity and risk of
Barrett’s esophagus. Gastroenterology 2007;133:403-11.
11. Gupta R, Munoz JC, Garg P, Masri G, Nahman NS Jr, Lambiase LR.: Mediastinal pancreatic
pseudocyst-a case report and review of the literature. MedGenMed 2007;9:8.
12. Gurvits GE, Shapsis A, Lau N, Gualtieri N, Robilotti JG.: Acute esophageal necrosis: a rare syndrome.
J Gastroenterol 2007;42:29-38.
13. Hwang J, Weigel TL.: Acute esophageal necrosis: “black esophagus”. JSLS. 2007;11:165-7.
14. Iwata T, Kurita N, Nishioka M, Miyamoto H, Wakatsuki S, Sano T, Tashiro S, Shimada M.: p53 and
MIB-1 expression of esophageal carcinoma concominant with achalasia. Hepatogastroenterology
2007;54:1430-2.
15. Kerkhof M, Steyerberg EW, Kusters JG, Kuipers EJ, Siersema PD.: Predicting presence of intestinal
metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis. Endoscopy 2007;39:772-8.
16. Kerlin P, Jones D, Remedios M, Campbell C.: Prevalence of eosinophilic esophagitis in adults with
food bolus obstruction of the esophagus. J Clin Gastroenterol 2007;41:356-61.
17. Khan M, Santana J, Donnellan C, Preston C, Moayyedi P.: Medical treatments in the short term
management of reflux oesophagitis. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD003244.
18. Kim YH, Choi SY.: Black esophagus with concomitant candidiasis developed after diabetic ketoacidosis.
World J Gastroenterol 2007;13:5662-3.
19. Koop H.: [Strategies for monitoring patients with Barrett’s esophagus–contra]. Dtsch Med Wochenschr.
2007;132:1769.
20. Kovács Z, Kerékgyártó O.: Psychological factors, quality of life, and gastrointestinal symptoms in
patients with erosive and non-erosive reflux disorder. Int J Psychiatry Med. 2007;37:139-50.
21. Leodolter A, Penagini R.: On-demand therapy is a valid strategy in GERD patients: pros and cons. Dig
Dis 2007;25:175-8.
22. Lucendo AJ, Castillo P, Martín-Chávarri S, Carrión G, Pajares R, Pascual JM, Manceñido N, Erdozain JC.:
Manometric findings in adult eosinophilic oesophagitis: a study of 12 cases. Eur J Gastroenterol Hepatol
2007;19:417-24.
23. Mclaughlin SA, Nguyen JH.: Conservative management of nongangrenous esophageal and gastric
pneumatosis. Am Surg 2007;73:862-4.
24. Merati AL, Tseng J, Blumin JH, Toohill RJ, Jaradeh S.: Comparative neuromuscular histopathology of
cricopharyngeal achalasia patients with and without previous botulinum toxin treatment. Ann Otol Rhinol
Laryngol 2007;116:375-80.
25. Müller S, Pühl S, Vieth M, Stolte M.: Analysis of symptoms and endoscopic findings in 117 patients
with histological diagnoses of eosinophilic esophagitis. Endoscopy 2007; 39:339-44.
26. Nakamura H, Nakaji G, Shimazu H, Yasuda S, Odashiro K, Maruyama T, Kaji Y, Chishaki A.: Case of
paroxysmal atrial fibrillation improved after the administration of proton pump inhibitor for associated
reflux esophagitis. Fukuoka Igaku Zasshi 2007;98:270-6.
27. Nason KS, Farrow DC, Haigh G, Lee SP, Bronner MP, Rosen SN, Vaughan TL.: Gastric fluid bile
concentrations and risk of Barrett’s esophagus. Interact Cardiovasc Thorac Surg 2007;6:304-7.
28. Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN.:
Association of body mass index with heartburn, regurgitation ad esophagitis: Results of the
Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol 2007; 22:1728-1731.
29. Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV Jr, Nishioka N, Barr H,
A nyelõcsõ 53
Marcon N, Pedrosa M, Bronner MP, Grace M, Depot M; International Photodynamic Group for
High-Grade Dysplasia in Barrett’s Esophagus.: Five-year efficacy and safety of photodynamic
therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest Endosc 2007;66:460-8.
30. Pasha SF, DiBaise JK, Kim HJ, De Petris G, Crowell MD, Fleischer DE, Sharma VK.: Patient
characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: a case
series and systematic review of the medical literature. Dis Esophagus 2007;20:311-9.
31. Pohl D, Tutuian R.: Achalasia: an overview of diagnosis and treatment. J Gastrointestin Liver Dis
2007;16:297-303.
32. Qadeer MA, Dumot JA, Vargo JJ, Lopez AR, Rice TW.: Endoscopic clips for closing esophageal
perforations: case report and pooled analysis. Gastrointest Endosc 2007;66:605-11.
33. Saha A, Jarvis M, Thorpe JA, O’Regan DJ.: Atypical presentation of Boerhaave’s syndrome as
Enterococcal bacterial pericardial effusion. Interact Cardiovasc Thorac Surg 2007;6:130-2.
34. Sakamoto Y, Miura S.: [A case of mediastinal pancreatic pseudocyst with hemoptysis successfully treated
with total parenteral nutrition]. Nihon Kokyuki Gakkai Zasshi. 2007;45:582-6.
35. Savojardo D, Mangano M, Cantù P, Penagini R.: Multiple rapid swallowing in idiopathic achalasia:
evidence for patients’ heterogeneity. Neurogastroenterol Motil 2007;19:263-9.
36. Solt J, Sarlós G, Tabár B, Bertalan A.: [Treatment of large, esophageal perforations and mediastinitis with
a covered, removable metallic endoprosthesis and mediastinal drainage]. Orv Hetil. 2007 Aug 26;
148(34):1601-7.
37. Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN.: Morphologic features
are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol
2007;31:1733-41.
38. Trappe R, Pohl H, Forberger A, Schindler R, Reinke P.: Acute esophageal necrosis (black esophagus)
in the renal transplant recipient: manifestation of primary cytomegalovirus infection. Transpl Infect Dis
2007;9:42-5.
39. Wang TD, Triadafilopoulos G, Crawford JM, Dixon LR, Bhandari T, Sahbaie P, Friedland S, Soetikno R,
Contag CH.: Detection of endogenous biomolecules in Barrett’s esophagus by Fourier transform infrared
spectroscopy. Proc Natl Acad Sci U S A. 2007;104:15864-9.
40. Zagorowicz E, Jankowski J.: Molecular changes in the progression of Barrett’s oesophagus. Postgrad Med
J 2007;83:529-35.
